Cervarix
GSK seeks licence extensions
August 8, 2013Sales and Marketing Cervarix, EMA, GSK, Votrient
GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …
AstraZeneca’s Fluenz chosen for wider flu immunisation
July 26, 2012Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune
The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …
UK government drops Cervarix for Gardasil
November 28, 2011Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi
The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …
Gardasil better value for money than Cervarix, finds new study
September 28, 2011Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer
A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …
UK hails high uptake of cervical cancer vaccine
January 31, 2011Research and Development Cervarix, HPV
The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …
GSK’s Cervarix finally wins US approval
October 19, 2009Sales and Marketing Cervarix, GSK, US
US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …
Cervarix not to blame for UK post-vaccination death
October 5, 2009Sales and Marketing Cervarix, NHS, reg, vaccines
The death of a 14-year-old girl who died shortly after having received a cervical cancer vaccine was caused by an …
GSK faces fresh US delays over Cervarix
September 30, 2009Sales and Marketing Cervarix, GSK, vaccines
GSK faces new delays in the US over the approval of its cervical cancer vaccine Cervarix, after the FDA failed …
